The socioeconomic burden of hip fractures, the most severe osteoporotic fracture outcome, is increasing and the current clinical risk assessment lacks sensitivity. This study aimed to develop a method for improved prediction of hip fracture by incorporating measurements of bone microstructure and composition derived from HR-pQCT. In a prospective cohort study of 3028 community-dwelling women aged 75-80, all participants answered questionnaires and underwent baseline examinations of anthropometrics and bone by DXA and HR-pQCT. Medical records, a regional x-ray archive, and registers were used to identify incident fractures and death. Prediction models for hip, major osteoporotic fracture (MOF), and any fracture were developed using Cox proportional hazards regression and machine learning algorithms (neural network, random forest, ensemble, and Extreme Gradient Boosting). In the 2856 (94.3%) women with complete HR-pQCT data at 2 tibia sites (distal and ultra-distal), the median follow-up period was 8.0 yr, and 217 hip, 746 MOF, and 1008 any type of incident fracture occurred. In Cox regression models adjusted for age, BMI, clinical risk factors (CRFs), and FN BMD, the strongest predictors of hip fracture were tibia total volumetric BMD and cortical thickness. The performance of the Cox regression-based prediction models for hip fracture was significantly improved by HR-pQCT (time-dependent AUC; area under receiver operating characteristic curve at 5 yr of follow-up 0.75 [0.64-0.85]), compared to a reference model including CRFs and FN BMD (AUC = 0.71 [0.58-0.81], p < .001) and a Fracture Risk Assessment Tool risk score model (AUC = 0.70 [0.60-0.80], p < .001). The Cox regression model for hip fracture had a significantly higher accuracy than the neural network-based model, the best-performing machine learning algorithm, at clinically relevant sensitivity levels. We conclude that the addition of HR-pQCT parameters improves the prediction of hip fractures in a cohort of older Swedish women.

Despite decades of advancements in diagnostic MRI, 30%-50% of temporal lobe epilepsy (TLE) patients remain categorized as 'non-lesional' (i.e. MRI negative) based on visual assessment by human experts. MRI-negative patients face diagnostic uncertainty and significant delays in treatment planning. Quantitative MRI studies have demonstrated that MRI-negative patients often exhibit a TLE-specific pattern of temporal and limbic atrophy that might be too subtle for the human eye to detect. This signature pattern could be translated successfully into clinical use via advances in artificial intelligence in computer-aided MRI interpretation, thereby improving the detection of brain 'lesional' patterns associated with TLE. Here, we tested this hypothesis by using a three-dimensional convolutional neural network applied to a dataset of 1178 scans from 12 different centres, which was able to differentiate TLE from healthy controls with high accuracy (85.9% ± 2.8%), significantly outperforming support vector machines based on hippocampal (74.4% ± 2.6%) and whole-brain (78.3% ± 3.3%) volumes. Our analysis focused subsequently on a subset of patients who achieved sustained seizure freedom post-surgery as a gold standard for confirming TLE. Importantly, MRI-negative patients from this cohort were accurately identified as TLE 82.7% ± 0.9% of the time, an encouraging finding given that clinically these were all patients considered to be MRI negative (i.e. not radiographically different from controls). The saliency maps from the convolutional neural network revealed that limbic structures, particularly medial temporal, cingulate and orbitofrontal areas, were most influential in classification, confirming the importance of the well-established TLE signature atrophy pattern for diagnosis. Indeed, the saliency maps were similar in MRI-positive and MRI-negative TLE groups, suggesting that even when humans cannot distinguish more subtle levels of atrophy, these MRI-negative patients are on the same continuum common across all TLE patients. As such, artificial intelligence can identify TLE lesional patterns, and artificial intelligence-aided diagnosis has the potential to enhance the neuroimaging diagnosis of TLE greatly and to redefine the concept of 'lesional' TLE.

The incidence of Alzheimer's disease is rising with the increasing elderly population worldwide. While no cure exists, early diagnosis can significantly slow disease progression. Computer-aided diagnostic systems are becoming critical tools for assisting in the early detection of Alzheimer's disease. In this systematic review, we aim to evaluate recent advancements in computer-aided decision support systems for Alzheimer's disease diagnosis, focusing on data modalities, machine learning methods, and performance metrics. We conducted a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies published between 2021 and 2024 were retrieved from PubMed, IEEEXplore and Web of Science, using search terms related to Alzheimer's disease classification, neuroimaging, machine learning, and diagnostic performance. A total of 39 studies met the inclusion criteria, focusing on the use of Magnetic Resonance Imaging, Positron Emission Tomography, and biomarkers for Alzheimer's disease classification using machine learning models. Multimodal approaches, combining Magnetic Resonance Imaging with Positron Emission Tomography and Cognitive assessments, outperformed single-modality studies in diagnostic accuracy reliability. Convolutional Neural Networks were the most commonly used machine learning models, followed by hybrid models and Random Forest. The highest accuracy reported for binary classification was 100%, while multi-class classification achieved up to 99.98%. Techniques like Synthetic Minority Over-sampling Technique and data augmentation were frequently employed to address data imbalance, improving model generalizability. Our review highlights the advantages of using multimodal data in computer-aided decision support systems for more accurate Alzheimer's disease diagnosis. However, we also identified several limitations, including data imbalance, small sample sizes, and the lack of external validation in most studies. Future research should utilize larger, more diverse datasets, incorporate longitudinal data, and validate models in real-world clinical trials. Additionally, there is a growing need for explainability in machine learning models to ensure they are interpretable and trusted in clinical settings. While computer-aided decision support systems show great promise in improving the early diagnosis of Alzheimer's disease, further work is needed to enhance their robustness, generalizability, and clinical applicability. By addressing these challenges, computer-aided decision support systems could play a pivotal role in the early detection and management of Alzheimer's disease, potentially improving patient outcomes and reducing healthcare costs.

Statistical Shape Models are machine learning tools in computational orthopedics that enable the study of anatomical variability and the creation of synthetic models for pathogenetic analysis and surgical planning. Current models of the glenohumeral joint either describe individual bones or are limited to non-pathologic datasets, failing to capture coupled shape variation in arthropathic anatomy. We aimed to develop a novel combined scapula-proximal-humerus model applicable to clinical populations. Preoperative computed tomography scans from 45 Reverse Total Shoulder Arthroplasty patients were used to generate three-dimensional models of the scapula and proximal humerus. Correspondence point clouds were combined into a two-body shape model using Principal Component Analysis. Individual scapula-only and proximal-humerus-only shape models were also created for comparison. The models were validated using compactness, specificity, generalization ability, and leave-one-out cross-validation. The modes of variation for each model were also compared. The combined model was described using eigenvector decomposition into single body models. The models were further compared in their ability to predict the shape of one body when given the shape of its counterpart, and the generation of diverse realistic synthetic pairs de novo. The scapula and proximal-humerus models performed comparably to previous studies with median average leave-one-out cross-validation errors of 1.08 mm (IQR: 0.359 mm), and 0.521 mm (IQR: 0.111 mm); the combined model was similar with median error of 1.13 mm (IQR: 0.239 mm). The combined model described coupled variations between the shapes equalling 43.2% of their individual variabilities, including the relationship between glenoid and humeral head erosions. The combined model outperformed the individual models generatively with reduced missing shape prediction bias (> 10%) and uniformly diverse shape plausibility (uniformity p-value < .001 vs. .59). This study developed the first two-body scapulohumeral shape model that captures coupled variations in arthropathic shoulder anatomy and the first proximal-humeral statistical model constructed using a clinical dataset. While single-body models are effective for descriptive tasks, combined models excel in generating joint-level anatomy. This model can be used to augment computational analyses of synthetic populations investigating shoulder biomechanics and surgical planning.

The thalamus plays a crucial role in sensory processing, emotional regulation, and cognitive functions, and its dysregulation may be implicated in psychosis. The aim of the present study was to examine the differences in thalamic subregional volumes between pediatric bipolar disorder patients with (P-PBD) and without psychotic symptoms (NP-PBD). Participants including 28 P-PBD, 26 NP-PBD, and 18 healthy controls (HCs) underwent structural magnetic resonance imaging (sMRI) scanning using a 3.0T MRI scanner. All T1-weighted imaging data were processed by FreeSurfer 7.4.0 software. The volumetric differences of thalamic subregions among three groups were compared by using analyses of covariance (ANCOVA) and post-hoc analyses. Additionally, we applied a standard support vector classification (SVC) model for pairwise comparison among the three groups to identify brain regions with significant volumetric differences. The ANCOVA revealed that significant volumetric differences were observed in the left pulvinar anterior (L_PuA) and left reuniens medial ventral (L_MV-re) thalamus among three groups. Post-hoc analysis revealed that patients with P-PBD exhibited decreased volumes in the L_PuA and L_MV-re when compared to the NP-PBD group and HCs, respectively. Furthermore, the SVC model revealed that the L_MV-re volume exhibited the best capacity to discriminate P-PBD from NP-PBD and HCs. The present findings demonstrated that reduced thalamic subregional volumes in the L_PuA and L_MV-re might be associated with psychotic symptoms in PBD.

Accurate preoperative discrimination of salivary gland pleomorphic adenoma (SPA) stromal subtypes is essential for therapeutic plannings. We aimed to establish and test machine learning (ML) models for classification of stromal subtypes in SPA based on ultrasound histogram analysis. A total of 256 SPA patients were enrolled in the study and categorized into two groups: stroma-low and stroma-high. The dataset was split into a training cohort with 177 patients and a validation cohort with 79 patients. The least absolute shrinkage and selection operator (LASSO) regression identified optimal features, which were then utilized to build predictive models using logistic regression (LR) and eight ML algorithms. The effectiveness of the models was evaluated using a range of performance metrics, with a particular focus on the area under the receiver operating characteristic curve (AUC). After LASSO regression, six key features (lesion size, shape, cystic areas, vascularity, mean, and skewness) were selected to develop predictive models. The AUCs ranged from 0.575 to 0.827 for the nine models. The support vector machine (SVM) algorithm achieved the highest performance with an AUC of 0.827, accompanied by an accuracy of 0.798, precision of 0.792, recall of 0.862, and an F1 score of 0.826. The LR algorithm also exhibited robust performance, achieving an AUC of 0.818, slightly trailing behind the SVM algorithm. Decision curve analysis indicated that the SVM-based model provided superior clinical utility compared to other models. The ML model based on ultrasound histogram analysis offers a precise and non-invasive approach for preoperative categorization of stromal subtypes in SPA.

During radiation therapy, the natural movement of organs can lead to underdosing the cancer and overdosing the healthy tissue, compromising treatment efficacy. Real-time image-guided adaptive radiation therapy can track the tumour and account for the motion. Typically, fiducial markers are implanted as a surrogate for the tumour position due to the low radiographic contrast of soft tissues in kilovoltage (kV) images. A segmentation approach that does not require markers would eliminate the costs, delays, and risks associated with marker implantation. We trained patient-specific conditional Generative Adversarial Networks for prostate segmentation in kV images. The networks were trained using synthetic kV images generated from each patient's own imaging and planning data, which are available prior to the commencement of treatment. We validated the networks on two treatment fractions from 30 patients using multi-centre data from two clinical trials. Here, we present a large-scale proof-of-principle study of x-ray-based markerless prostate segmentation for globally available cancer therapy systems. Our results demonstrate the feasibility of a deep learning approach using kV images to track prostate motion across the entire treatment arc for 30 patients with prostate cancer. The mean absolute deviation is 1.4 and 1.6 mm in the anterior-posterior/lateral and superior-inferior directions, respectively. Markerless segmentation via deep learning may enable real-time image guidance on conventional cancer therapy systems without requiring implanted markers or additional hardware, thereby expanding access to real-time adaptive radiation therapy.

This study introduces a novel methodology to enhance nipple segmentation in digital mammography, a critical component for accurate medical analysis and computer-aided detection systems. The nipple is a key anatomical landmark for multi-view and multi-modality breast image registration, where accurate localization is vital for ensuring image quality and enabling precise registration of anomalies across different mammographic views. The proposed approach significantly outperforms baseline methods, particularly in challenging cases where previous techniques failed. It achieved successful detection across all cases and reached a mean Intersection over Union (mIoU) of 0.63 in instances where the baseline failed entirely. Additionally, it yielded nearly a tenfold improvement in Hausdorff distance and consistent gains in overlap-based metrics, with the mIoU increasing from 0.7408 to 0.8011 in the craniocaudal (CC) view and from 0.7488 to 0.7767 in the mediolateral oblique (MLO) view. Furthermore, its generalizability suggests the potential for application to other breast imaging modalities and related domains facing challenges such as class imbalance and high variability in object characteristics.

Novel artificial intelligence tools have the potential to significantly enhance productivity in medicine, while also maintaining or even improving treatment quality. In this study, we aimed to evaluate the current capability of ChatGPT-4.0 to accurately interpret multimodal musculoskeletal tumor cases.We created 25 cases, each containing images from X-ray, computed tomography, magnetic resonance imaging, or scintigraphy. ChatGPT-4.0 was tasked with classifying each case using a six-option, two-choice question, where both a primary and a secondary diagnosis were allowed. For performance evaluation, human raters also assessed the same cases.When only the primary diagnosis was taken into account, the accuracy of human raters was greater than that of ChatGPT-4.0 by a factor of nearly 2 (87% vs. 44%). However, in a setting that also considered secondary diagnoses, the performance gap shrank substantially (accuracy: 94% vs. 71%). Power analysis relying on Cohen's w confirmed the adequacy of the sample set size (n: 25).The tested artificial intelligence tool demonstrated lower performance than human raters. Considering factors such as speed, constant availability, and potential future improvements, it appears plausible that artificial intelligence tools could serve as valuable assistance systems for doctors in future clinical settings. · ChatGPT-4.0 classifies musculoskeletal cases using multimodal imaging inputs.. · Human raters outperform AI in primary diagnosis accuracy by a factor of nearly two.. · Including secondary diagnoses improves AI performance and narrows the gap.. · AI demonstrates potential as an assistive tool in future radiological workflows.. · Power analysis confirms robustness of study findings with the current sample size.. · Bosbach WA, Schoeni L, Beisbart C et al. Evaluating the Diagnostic Accuracy of ChatGPT-4.0 for Classifying Multimodal Musculoskeletal Masses: A Comparative Study with Human Raters. Rofo 2025; DOI 10.1055/a-2594-7085.

This paper describes PARADIM, a digital infrastructure designed to support research at the interface of data science and medical imaging, with a focus on Research Data Management best practices. The platform is built from open-source components and rooted in the FAIR principles through strict compliance with the DICOM standard. It addresses key needs in data curation, governance, privacy, and scalable resource management. Supporting every stage of the data science discovery cycle, the platform offers robust functionalities for user identity and access management, data de-identification, storage, annotation, as well as model training and evaluation. Rich metadata are generated all along the research lifecycle to ensure the traceability and reproducibility of results. PARADIM hosts several medical image collections and allows the automation of large-scale, computationally intensive pipelines (e.g., automatic segmentation, dose calculations, AI model evaluation). The platform fills a gap at the interface of data science and medical imaging, where digital infrastructures are key in the development, evaluation, and deployment of innovative solutions in the real world.